Wegovy took over 80% of South Korea's obesity drug market within nine months of its October 2024 launch, but that lead has since slipped, The Chosun Ilbo reports.
Recap by typeshit. Full story at The Chosun Ilbo on MSN.
Sam Stone mixed GLP-1 Daily Support powder into a smoothie daily and came away with stomach aches and doubts about what it does.
Dr Desmond Wai shares the Novo Nordisk news and notes the FDA cleared semaglutide for fatty liver disease in the US more than a year earlier.
A short personal check-in from a creator who tags her post with tirzepatide. No numbers or details beyond the update itself.
The two actors chat about what keeps them working, how they approach fitness, and look back on Mona Singh's show Jassi Jaissi Koi Nahin.
The anatomy channel argues the hollowed look isn't a direct drug side effect but what quick fat loss does to the face. A full breakdown is up on YouTube.
A short explainer on whether the hollow look called Ozempic face comes from losing fat or from the drug itself.
Loading…